30-Hydroxygambogic acid

CAS No. 881027-36-7

30-Hydroxygambogic acid ( )

Catalog No. M31208 CAS No. 881027-36-7

30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    30-Hydroxygambogic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.
  • Description
    30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    881027-36-7
  • Formula Weight
    644.8
  • Molecular Formula
    C38H44O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chem Biodivers. 2006 Jan;3(1):101-5.
molnova catalog
related products
  • IFN alpha-IFNAR-IN-1...

    IFN alpha-IFNAR-IN-1 hydrochloride is an inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 hydrochloride inhibits MVA-induced IFN-α responses by BM-pDCs with IC50 of 2-8 μM.

  • Retronecine

    Retronecine acts as the better competitor for the competitive inhibition of antibodies to Retronecine.

  • Dibenzothiophene

    Dibenzothiophene (DBT) is a model compound for organic sulfur in fossil fuels.